In two articles in this issue (Fundam. Appl. Toxicol. 37, (2) (3) (4) (5) (6) , we present something new: two papers on the opposite sides of an argument. In this case, the argument regards culling of litters. For many scientists performing breeding studies in a regulatory context, the culling of litters to a standard size shortly after birth (generally 3-5/gender/ litter) is an accepted practice. While the origins of this practice seem to be lost in the mists of time, the perceived benefits (reduced manpower requirements, likely reductions in variations in pup growth rates due solely to litter size differences) appear to justify the random discarding of some animals. This is especially true when the adverse effects of culling are far less obvious.
As one reads these papers, it becomes obvious that there are painfully few data collected from prospective studies. Although our authors are able to marshal some support for their arguments, it is clear that what is really needed to address the question of whether or not culling is a good thing are both data (from some prospective studies designed to answer some specific questions) and a regulatory context. The studies need to be carefully designed with input from the industrial, academic, and regulatory communities to answer questions such as: To what extent does the practice of culling affect the responses of particular endpoints? What limitations on conclusions are imposed by culling or by not culling? What are the regulatory implications of culling? Should the rules and practices followed in different countries be harmonized? Probably the most difficult areas to agree upon will be: What are the important questions to answer, and what assumptions can we accept? Will we even share common assumptions as we try to design such studies? (These discussions are likely to be similar to the situation where a meeting between two parties with deep and ancient disagreements is categorized in diplomatese as "a full and frank exchange of views.") While we do not expect these brief presentations alone to change the mindset or position of any regulatory agency or involved scientist, we hope that this laying out of the arguments might stimulate some rational debate. This exercise can be judged successful if some collaborative prospective studies are designed to evaluate the effects of this practice on the outcome of our studies. We also hope that readers may be motivated to suggest other issues in toxicology that might benefit by having the viewpoints of different sides presented in depth in an open forum.
